Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,074 | 1,808 | 93.7% |
| Consulting Fee | $1,216 | 2 | 4.7% |
| Travel and Lodging | $340.40 | 1 | 1.3% |
| Education | $70.17 | 9 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,571 | 184 | $0 (2024) |
| Novo Nordisk Inc | $1,813 | 136 | $0 (2024) |
| PFIZER INC. | $1,548 | 167 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,384 | 66 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,351 | 11 | $0 (2021) |
| Lilly USA, LLC | $1,342 | 119 | $0 (2024) |
| Amgen Inc. | $1,177 | 88 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,002 | 75 | $0 (2024) |
| Amarin Pharma Inc. | $946.13 | 81 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $862.17 | 86 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,382 | 148 | ABBVIE INC. ($630.97) |
| 2023 | $2,710 | 180 | ABBVIE INC. ($520.73) |
| 2022 | $2,746 | 191 | ABBVIE INC. ($432.22) |
| 2021 | $3,750 | 179 | Biohaven Pharmaceuticals, Inc. ($1,325) |
| 2020 | $2,297 | 148 | Allergan, Inc. ($305.67) |
| 2019 | $3,178 | 259 | PFIZER INC. ($359.47) |
| 2018 | $4,254 | 336 | Edwards Lifesciences Corporation ($593.82) |
| 2017 | $4,382 | 379 | AstraZeneca Pharmaceuticals LP ($443.17) |
All Payment Transactions
1,820 individual payment records from CMS Open Payments — Page 1 of 73
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Cardio-renal | ||||||
| 12/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Hyperthyroidism | ||||||
| 12/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.68 | General |
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Neuromodulation | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: PAIN | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Neuromodulation | ||||||
| 10/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.86 | General |
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,183 | 2,842 | $456,184 | $120,328 |
| 2022 | 38 | 3,248 | 4,953 | $903,686 | $240,451 |
| 2021 | 44 | 4,287 | 6,876 | $1.2M | $337,670 |
| 2020 | 43 | 4,271 | 6,383 | $1.2M | $278,539 |
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 330 | 492 | $162,360 | $39,782 | 24.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 319 | 319 | $113,883 | $39,472 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 188 | 245 | $54,390 | $14,217 | 26.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 24 | 24 | $12,288 | $3,843 | 31.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 219 | 222 | $12,210 | $2,913 | 23.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 243 | 262 | $11,266 | $2,712 | 24.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 49 | 244 | $25,535 | $2,385 | 9.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 106 | 116 | $8,004 | $1,893 | 23.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 143 | 190 | $7,600 | $1,809 | 23.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $8,964 | $1,692 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $8,080 | $1,636 | 20.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 28 | 32 | $5,248 | $1,288 | 24.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 21 | 41 | $5,166 | $1,208 | 23.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 90 | 100 | $3,700 | $884.00 | 23.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 91 | 104 | $3,328 | $791.44 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 79 | 81 | $819.00 | $680.40 | 83.1% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 14 | 14 | $2,366 | $566.30 | 23.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 28 | 28 | $2,100 | $504.56 | 24.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 14 | 14 | $1,554 | $406.14 | 26.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $1,176 | $373.38 | 31.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 12 | 14 | $1,470 | $354.06 | 24.1% |
| 92228 | Imaging of retina with remote review by physician | Office | 2023 | 28 | 28 | $1,578 | $305.65 | 19.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 32 | 36 | $1,260 | $298.44 | 23.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 15 | $780.00 | $133.08 | 17.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 16 | 91 | $728.00 | $101.02 | 13.9% |
About Dr. Thimos Paschalis, M.D
Dr. Thimos Paschalis, M.D is a Internal Medicine healthcare provider based in Shenandoah, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689733669.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thimos Paschalis, M.D has received a total of $25,701 in payments from pharmaceutical and medical device companies, with $2,382 received in 2024. These payments were reported across 1,820 transactions from 93 companies. The most common payment nature is "Food and Beverage" ($24,074).
As a Medicare-enrolled provider, Paschalis has provided services to 13,989 Medicare beneficiaries, totaling 21,054 services with total Medicare billing of $976,988. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Shenandoah, TX
- Active Since 12/06/2006
- Last Updated 09/09/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689733669
Products in Payments
- NURTEC ODT (Drug) $1,733
- VRAYLAR (Drug) $1,127
- Vascepa (Drug) $946.13
- FARXIGA (Drug) $891.68
- UBRELVY (Drug) $863.88
- JARDIANCE (Drug) $802.00
- Ozempic (Drug) $773.02
- XARELTO (Drug) $681.42
- ENTRESTO (Drug) $622.45
- XIFAXAN (Drug) $604.58
- TRULICITY (Drug) $601.09
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $449.23
- QULIPTA (Drug) $435.04
- CHANTIX (Drug) $420.06
- MYRBETRIQ (Drug) $414.08
- Kerendia (Drug) $355.79
- Dexcom G6 Transmitter (Medical Supply) $346.84
- Prolia (Biological) $328.95
- Aimovig (Biological) $320.55
- ELIQUIS (Drug) $315.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Shenandoah
George Manoukian, M.d, M.D
Internal Medicine — Payments: $252,502
Dr. Rajesh Venkataraman
Internal Medicine — Payments: $226,580
Paul Cunningham, M.d, M.D
Internal Medicine — Payments: $29,344
Dustin Agan, Md, MD
Internal Medicine — Payments: $28,308
Andrew Jackson, Md, MD
Internal Medicine — Payments: $18,799
Christopher Nguyen, M.d, M.D
Internal Medicine — Payments: $13,238